A study on the survival time, sex, weight and blood content of the Ehrlich Ascites Carcinoma involved tumour

Authors

  • Nagarjuna Reddy Vennapusa Department of Pharmacology, Karnataka College of Pharmacy Bangalore, Karnataka,
  • Nagarathna P. K. M Department of Pharmacology, Karnataka College of Pharmacy Bangalore, Karnataka,
  • Divya M. Department of Pharmacology, Karnataka College of Pharmacy Bangalore, Karnataka,

DOI:

https://doi.org/10.7439/ijpr.v3i2.44

Keywords:

Tigecycline, MRSA, Acinetobacter spp., multi drug resistance, India

Abstract

Experimental tumours have great importance in modelling, and Ehrlich ascites carcinoma (EAC) is one of the commonest tumours. EAC is referred to as an undifferentiated carcinoma and is originally hyperdiploid, has high transplantable capability, no-regression, rapid proliferation, shorter life span, 100% malignancy and also does not have tumour-specific transplantation antigen (TSTA). EAC resembles human tumours which are the most sensitive to chemotherapy due to the fact that they are undifferentiated and that they have a rapid growth rate. The ideal drug being ineffective or minimally effective for normal cells have been focused on, and at this point, the usage of natural sources as an alternative cancer therapy is thought to have a great value for cancer control and programs destructio n.

Downloads

Download data is not yet available.

Author Biography

  • Nagarjuna Reddy Vennapusa, Department of Pharmacology, Karnataka College of Pharmacy Bangalore, Karnataka,
    Pharmacology (M.Pharmacy)

Downloads

Published

2013-07-17

Issue

Vol. 3 No. 2 (2013): Apr-Jun

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Author must Submit Copyright form  After acceptance of Article

How to Cite

1.
Vennapusa NR, P. K. M N, M. D. A study on the survival time, sex, weight and blood content of the Ehrlich Ascites Carcinoma involved tumour. Int J of Pharmc Res [Internet]. 2013 Jul. 17 [cited 2025 Mar. 14];3(2):27-35. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/1234
Crossref
Scopus
Google Scholar
Europe PMC